Page 1 of Clinical Trials for omega-3-acid ethyl esters, 99 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension
Last Updated: December 10, 2009
Condition(s): Hypertriglyceridemia
2
Completed
Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects
Last Updated: December 10, 2009
Condition(s): Hypertriglyceridemia
3
Completed
A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
Last Updated: January 22, 2011
Condition(s): Hypertriglyceridemia
4
Completed
Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
Last Updated: September 3, 2010
Condition(s): Hypertriglyceridemia
5
Completed
Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects
Last Updated: September 3, 2010
Condition(s): Hypertriglyceridemia
6
Completed
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
Last Updated: September 23, 2010
Condition(s): Fibrillation, Atrial; Atrial Fibrillation
7
Withdrawn
Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia
Last Updated: July 27, 2011
Condition(s): Hypertriglyceridemia
8
Completed
Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
Last Updated: March 10, 2008
Condition(s): Human Immunodeficiency Virus; Ischemic Heart Disease
9
Recruiting
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Last Updated: June 9, 2010
Condition(s): Non-Alcoholic Fatty Liver Disease
10
Not yet recruiting
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
Last Updated: March 11, 2010
Condition(s): Coronary Artery Disease
11
Active, not recruiting
Niacin, N-3 Fatty Acids and Insulin Resistance
Last Updated: March 15, 2011
Condition(s): Metabolic Syndrome; Hypertriglyceridemia
12
Completed
Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals
Last Updated: January 6, 2012
Condition(s): Hypertriglyceridemia
13
Completed
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
Last Updated: April 28, 2008
Condition(s): Mixed Dyslipidemia
14
Completed
Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation
Last Updated: January 5, 2012
Condition(s): Severe Hypertriglyceridemia
15
Terminated
Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides
Last Updated: November 3, 2011
Condition(s): Hypertriglyceridemia
16
Completed
Effects of Omacor and Aspirin on Platelet Function
Last Updated: June 2, 2008
Condition(s): Healthy
17
Recruiting
Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Heart Function in Patients With Mitral Valve Disease
Last Updated: June 21, 2011
Condition(s): Mitral Valve Regurgitation; Left Atrium Dilatation and Hypertrophy; Mitochondrial Dysfunction in the Heart; Cardiomyocyte Apoptosis; Cardiac Inflammation
18
Completed
Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
Last Updated: March 10, 2008
Condition(s): Kidney Failure, Chronic
19
Recruiting
Triglyceride Lowering Study
Last Updated: July 7, 2009
Condition(s): Hypertriglyceridemia
20
Completed
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Last Updated: November 17, 2011
Condition(s): Cardiovascular Risk; HIV Infection

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=omega-3-acid+ethyl+esters

Page 1 of Clinical Trials for omega-3-acid ethyl esters, 99 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About